Amgen completes acquisition of Mustafa Nevzat Pharmaceuticals
Posted: 12 June 2012 | | No comments yet
Amgen announced the completion of the acquisition of more than 99 percent of the shares of Mustafa Nevzat Pharmaceuticals…
Amgen (NASDAQ: AMGN) today announced the completion of the acquisition of more than 99 percent of the shares of Mustafa Nevzat Pharmaceuticals, a privately held Turkish company.
The all-cash transaction significantly expands Amgen’s presence in Turkey and the surrounding region, which includes several fast-growing, priority markets for Amgen. The acquisition was initially announced on April 25.
